1 recruiting. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Immunologic Suppression: new trials by email Literature Review of Immunologic Suppression trials Research Report on Immunologic Suppression
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological Malignancies Cyclophosphamide, ATG - Bone Marrow Transplant Complications, Graft Versus Host Disease | Phase 2 / Phase 3 | Recruiting | Hospital Israelita Albert Einstein | 50 | 2018-11-06 | 2019-02-01 |
Graft vs Host Disease (1) · Hematologic Neoplasms (1) · Virus Diseases (1)
Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Infections (1) · Neoplasms (1) · Neoplasms by Site (1)
Cyclophosphamide (1) · thymoglobulin (1)
Hospital Israelita Albert Einstein (1)
Brazil (1)
Andreza A Feitosa Ribeiro, PhD (1) · Nelson Hamerschlak, PhD (1)